Last reviewed · How we verify

NCT04022629: ASSET 2

ASSET 2 Study: Long-Term Follow-up of a Randomised Control Trial

Completed Phase 2, PHASE3 Last updated 22 January 2020
What this trial tests

Phase 2, PHASE3 trial testing Arthroscopic Washout Only in Shoulder Dislocation in 88 participants. Completed in 1 January 2020.

Timeline
1 May 2019
Primary endpoint
30 July 2019
1 January 2020

Quick facts

Lead sponsorRoyal Infirmary of Edinburgh
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment88
Start date1 May 2019
Primary completion30 July 2019
Estimated completion1 January 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Royal Infirmary of Edinburgh

Who can join

Adults 25 to 55, any sex, with Shoulder Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to measure the long-term efficacy of arthroscopic Bankart repair for first-time anterior shoulder dislocation in terms of recurrent instability and functional outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Shoulder Dislocation

Currently open trials in the same condition.

Other Royal Infirmary of Edinburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04022629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing